Optimize your EHR use today to enhance a collaborative treatment relationship with your patients.
Medscape Diabetes & Endocrinology
Tag: Diabetes & Endocrinology
Trained Imagers Catch Most Diabetic Retinopathy at Point of Care
Trained nonphysician imagers are able to evaluate patients for diabetic retinopathy in primary care, using a novel technology, ultrawide field imaging, reducing the work load of central reading centers. Medscape Medical News
New Eye Scan Predicts Peripheral Neuropathy in Diabetes
Could corneal confocal microscopy represent a new technique for predicting peripheral diabetic neuropathy? The data suggest so, but there are still some hurdles to overcome. Medscape Medical News
Rituximab May Be Helpful in Graves’ Orbitopathy
Compared to IV methylprednisolone for Graves’ orbitopathy, rituximab offers a number of advantages, Italian researchers say. Reuters Health Information
Graves’ Orbitopathy: Double Vision Worse With Less Disease
The counterintuitive findings mean that Graves’ orbitopathy patients should be screened for restrictions in eye motility, which seems to correlate most with double vision, say the researchers. Medscape Medical News
World War Parallels Diabetes Epidemic
EASD President Andrew Boulton reflects on how lessons learned from WWI could help address the current epidemic of diabetes.
Medscape Diabetes & Endocrinology
Corneal Microscopy Detects Diabetic Autonomic Neuropathy
A study shows close correlation of corneal-nerve parameters with standard measures of diabetic autonomic neuropathy, yielding good sensitivity and specificity for making the diagnosis. Medscape Medical News
Statins Don’t Up Diabetic Microvascular Disease Risk
An analysis of a large database in Denmark suggests that statin use among adults who later develop diabetes does not raise the risk for microvascular complications and may even protect against them. Medscape Medical News
Glaucoma Drug Eyed as Novel Diabetes Treatment ‘Archetype’
An old glaucoma drug, methazolamide, improved glucose control in a small study, probably due to a distinct mechanism that the manufacturer, Verva, hopes to pursue. Medscape Medical News
Diabetic Vision Loss: Screening Key, Blacks at Greatest Risk
One in 25 US adults with diabetes over age 40 has diabetic macular edema, and African Americans are at higher risk, a new study indicates. The lead author is calling for better screening. Medscape Medical News
Novel Eye Measure Finds Neuropathy in Prediabetes
Corneal confocal microscopy detected evidence of small-fiber neuropathy in patients who don’t even have diabetes yet but who have impaired glucose tolerance. Medscape Medical News
No Change in Retinopathy in Diabetes 2 Years After Surgery
Two years after diabetic patients undergo bariatric surgery, diabetic retinopathy has neither worsened nor improved, data from STAMPEDE show. Regular eye exams are still important, investigators stress. Medscape Medical News
Photobiomodulation in Diabetic Macular Edema
Patients with non-center-involving diabetic macular edema (NCDME) may benefit from photobiomodulation, a new case series suggests. Reuters Health Information
Video Simulation Tool Might Help Prevent Diabetic Retinopathy
A Moroccan ophthalmologist has developed a video tool depicting what life might look like with diabetic retinopathy, in the hope that its use will encourage diabetes patients to better self-care. Medscape Medical News
Anti-VEGF Therapy for Diabetic Macular Edema
Why do anti-VEGF inhibitors improve visual outcomes in DME? Therapeutic Advances in Endocrinology and Metabolism
Diabetes Complications Predict Worse Quality of Life
The treatment group to which type 1 diabetes patients were originally assigned in the DCCT study was not associated with long-term quality of life, but diabetes complications were. Medscape Medical News
Optimal Treatment of Diabetic Retinopathy
Which patients with diabetic retinopathy benefit most from VEGF inhibitor therapy? Therapeutic Advances in Endocrinology and Metabolism
Look AHEAD: No CVD Reduction, But Kidneys, Eyes Benefit
The primary end point, which was the first occurrence of death from cardiovascular causes, nonfatal MI, nonfatal stroke, or hospitalization for angina, occurred in 403 patients in the intervention arm and 418 patients in the control arm. This differenc…
DCCT: HbA1c Matters Today, Tomorrow, and 20 Years On
New follow-up data from the landmark Diabetes Control and Complications Trial demonstrate the ongoing benefit from intensive management of type 1 diabetes. Medscape Medical News
New Medication May Improve Sleep in Blind People
A phase 3 study shows that tasimelteon can improve symptoms in blind people who experience sleep disruption due to a circadian-rhythm disorder. Medscape Medical News